Skip to main content
OpenTrials
Completed

NCT Number: NCT00203645

Minimal and Brief Treatments for Pathological Gamblers

The purpose of the study is to examine whether problem gamblers who receive therapy calls in addition to a self-help manual will be more likely to quit or cut back on their gambling when compared with problem gamblers who receive just the manual.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University of Calgary

Calgary, Alberta, T2N 1N4, Canada

About this study

With gambling becoming more accessible, the occurrence of problems related to gambling are on the rise. The costs of problem gambling are enormous.There are social and economic costs, the gambler can sometimes lose a significant relationship, job, or commit an illegal activity. Pathological gamblers are also at risk for developing a general medical condition related to stress. There is a high risk of suicide and problem gamblers also have increased rates of mental health disorders. Relatively few people choose to attend formal treatment programs so it's important to provide a range of options to make treatment more accessible. The present study examines the effectiveness of minimal and brief interventions delivered by the telephone.

Comparison(s): The "Workbook Only Control" condition involves receiving the self-help booklet through the mail after a brief telephone assessment. The "Minimal Treatment" condition involves receiving the same workbook but also having a motivational enhancement intervention by telephone. The "Brief Treatment" condition provides the workbook, motivational enhancement, and follow-up support on six occasions spread over 36 weeks. The "Wait List Control" condition involves participants being assigned to a six week waiting list. Participants are assessed and after a six week waiting period they will have a reassessment at which time they will be sent the gambling self-help workbook.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Over age 17
  • Perception of a gambling problem and a score of 3 or higher (moderate risk) on the Canadian Problem Gambling Index.
  • Not involved in treatment at present.
  • Willingness to read a short book written in English as a major treatment.
  • Willing to have telephone contacts recorded.
  • Willing to provide follow-up data on gambling.
  • Willing to provide the name of a collateral to help locate them for follow-up interviews.
  • Must have gambled at least once in the past month

Exclusion criteria

  • Participants in the preliminary study will be excluded.

Treatment and study plan

Self-help treatment

Behavioral

Workbook "Becoming a Winner",

Other names: Bibliotherapy, motivational interviewing

Primary outcomes

  1. Days of Gambling

    Time frame: 3,6,9 12 months

  2. Money lost

    Time frame: 3,6,9 12 months

Secondary outcomes

  1. Gambling problem severity

    Time frame: 12 months

  2. Psychiatric symptoms

    Time frame: 12 months

  3. Self-efficacy

    Time frame: 3,6,9,12 months

Sponsors and collaborators

Lead sponsor

University of Calgary

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)

Registry information

Official study title

Minimal and Brief Treatments for Pathological Gamblers: Developing Effective Treatment Systems

Important dates

Study start
2003
Primary completion
2006
Study completion
2009
First posted
Sep 20, 2005
Registry last updated
Feb 16, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.